Friday, August 8, 2025

Aurora Debt Holders Agree to Convert 94% of $230 Million Debenture

Aurora Cannabis (TSX: ACB) (NYSE: ACB) is shedding a significant amount of its debt. The firm announced this morning that it has received confirmation from the majority of convertible debenture holders that they intend to convert current outstanding debt under the early conversion option. The result, is approximately $216.0 million worth of debt will be converted into common shares this week.

Aurora had originally received conversion commitment for $155.0 million worth of debt.

The announcement from Aurora is significant, as it enables the firm to focus its cash on other facets of the operation, such as paying down its accounts payable. The $230 million in convertible debentures coming due in March 2020 was previously a drag on the firms financial outlook, due to it becoming apparent that Aurora simply did not have the cash to pay it off.

With Aurora now receiving confirmation that 94% of the debt will be converted, shareholders will have to remain patient as they wait the week out to determine the conversion ratio. As per a filing made by Aurora on November 14, the debt will be converted at a 6% discount to the five day volume weighted average price that occurs between November 18, and November 22, 2019. The original news release issued in conjunction with the early conversion option did not identify this time period for the calculation.

Aurora Cannabis closed yesterday’s session at $3.00 on the TSX.


Information for this briefing was found via Sedar and Aurora Cannabis. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Gold/Silver: People Can Still Lose Money In This Bull Market!? | Rick Rule

He Said $300 Silver!? | Peter Krauth

Dollar Will Collapse, Gold and Silver Are the Only Safe Havens | Jim Rogers

Recommended

Nova Scotia Bans Forest Access to Prevent Wildfires

Cardiol Therapeutics Releases Positive Topline Results From Phase II Clinical Trial

Related News

Aurora Cannabis Attempts To Raise US$125 Million In Public Offering

It seems that Aurora Cannabis (TSX: ACB) (NYSE: ACB) is intending to use its recent...

Wednesday, November 11, 2020, 07:25:48 AM

Aurora Cannabis Files US$500 Million Base Shelf Prospectus, Reveals ATM Largely Complete

Aurora Cannabis (TSX: ACB) (NYSE: ACB) appears to be in need of money again. The...

Tuesday, October 27, 2020, 12:07:15 AM

Aurora Cannabis Acquires Undisclosed Stake In Dutch Cannabis Firm, Zero Details Provided

With its Canadian market share falling apart, Aurora Cannabis (TSX: ACB) has evidently placed its...

Monday, November 8, 2021, 08:42:23 AM

Aurora Cannabis, Aphria Said To Have Walked From Potential Merger Over Executive Compensation

It’s been reported by BNN Bloomberg that Aphria Inc (TSX: APHA) (NASDAQ: APHA) and Aurora...

Tuesday, July 14, 2020, 04:23:23 PM

Aurora Cannabis Posts Declining Q4 2021 Revenues Of $54.8 Million, Net Loss

Aurora Cannabis (TSX: ACB) this afternoon reported its fourth quarter financial results. The firm reported...

Monday, September 27, 2021, 06:16:23 PM